The Commerce secretary suggested on CNBC's "Squawk Box" that President Trump has repeatedly rejected potential deals in pursuit of better terms for the U.S.

US pharma majors, including Eli Lilly, Johnson & Johnson, and AbbVie, have already begun ramping up US investments in ...